Key Takeaways
- Pre-revenue valuation is a negotiation, not a calculation.
- The quality of the team and the size of the market set the upper bound.
- Comparable transactions tell you the market price, but your conviction should set your number.
Every investor who has written a seed check knows the experience. There is no revenue to model. The product is often still being built. The market size estimates are directional at best. And yet you have to put a number on the company and wire money on that basis.
Saim Abbasi spends more time on pre-revenue valuation than on any other part of the investment process at Iron Key Capital, because the entry price at seed stage has an outsized effect on returns that compounds through every subsequent round.
The Three Inputs That Actually Matter
In practice, pre-revenue seed valuation comes down to three things: the quality and track record of the team, the demonstrable size of the market, and the current competitive landscape in the space. Everything else is negotiation theater.
Team quality is the biggest swing factor. A repeat founder with one exit, even a modest one, will command a 20 to 40 percent premium over a first-time founder in the same space with comparable domain expertise. That premium is often justified. People who have taken a company through the chaotic middle part, the part between initial product-market fit and sustainable unit economics, have information that cannot be learned any other way.
Using Comparables Without Being Captured by Them
Comparable transactions are useful for sanity-checking a valuation, not for setting it. If every seed round in your space is closing at 8 to 12 million post-money and the company in front of you is asking for 15, that gap needs to be explained. Not necessarily rejected, but explained.
What Saim looks for in above-market seed valuations is a specific and defensible reason why this company is worth the premium. A signed LOI with a major enterprise customer before any code is shipped is a real reason. A founder who went to a prestigious accelerator is not.
When to Walk Away from the Valuation
The cleanest decision rule Saim Abbasi uses: if the valuation requires the company to hit an aggressive Series A milestone to return the fund on this position alone, the entry price is wrong. The investment should not depend on everything going perfectly. There should be a path to a reasonable outcome even if the company takes three times as long as projected and needs one pivot to find its market.
That discipline rules out a lot of deals. It also means the ones Iron Key backs tend to perform consistently rather than occasionally spectacularly and mostly badly.
"Valuing a pre-revenue startup is really just answering one question: how much would you pay to have this team working on this problem for the next decade?"